LivaNova

LivaNova PLC is a global medical technology company built on nearly five decades of experience and a relentless commitment to improve the lives of patients around the world. Our advanced technologies and breakthrough treatments provide meaningful solutions for the benefit of patients, healthcare professionals and healthcare systems.

At LivaNova, we understand the importance of bringing both clinical and economic value to our customers. We are a strong, market-leading medical technology and services company, offering a diverse product portfolio and global reach. LivaNova is listed on the NASDAQ stock exchange under the ticker symbol “LIVN.”

LivaNova has approximately 3,000 employees worldwide. We are headquartered in London (UK) and maintain a presence in more than 100 countries. LivaNova operates as two businesses:

We have a strong legacy as leaders in neuromodulation and cardiovascular solutions, providing products and therapies in distinct therapeutic areas to treat the head and heart. These include:
• Difficult-to-Treat Depression
• Drug-Resistant Epilepsy
• Obstructive Sleep Apnea
• Advanced Circulatory Support
• Heart Failure
• Cardiopulmonary

At LivaNova, we serve health and improve lives. Day by day. Life by life.